Neuropathological alterations in Alzheimer disease

Cited by (1,028)

Items 701–800 of 1,028

1. Electroacupuncture at the Baihui acupoint alleviates cognitive impairment and exerts neuroprotective effects by modulating the expression and processing of brain-derived neurotrophic factor in APP/PS1 transgenic mice
   Ruhui Lin, Jixiang Chen, Xiaojie Li, Jingjie Mao, Yunan Wu, Peiyuan Zhuo, YINZHENG ZHANG, Weilin Liu, Jia Huang, Jing Tao et al. · 2015 · Molecular Medicine Reports
2. The Peculiar Role of the A2V Mutation in Amyloid-β (Aβ) 1–42 Molecular Assembly
   Massimo Messa, Laura Colombo, Elena Del Favero, Laura Cantú, Tatiana Stoilova, Alfredo Cagnotto, Alessandro Rossi, Michela Morbin, Giuseppe Di Fede, Fabrizio Tagliavini et al. · 2014 · Journal of Biological Chemistry
3. Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
   Niyanta N. Kumar, Michelle E. Pizzo, Geetika Nehra, Brynna Wilken-Resman, Sam Boroumand, Robert G. Thorne · 2018 · Bioconjugate Chemistry
4. The emerging role of neutrophils in neurodegeneration
   Barbara Rossi, Gabriela Constantin, Elena Zenaro · 2019 · Immunobiology
5. Basic Limonoid modulates Chaperone-mediated Proteostasis and dissolve Tau fibrils
   Nalini Vijay Gorantla, Rashmi Ranjan Das, Hariharakrishnan Chidambaram, Tushar Dubey, Fayaj A. Mulani, Hirekodathakallu Venkataramaiah Thulasiram, Subashchandrabose Chinnathambi · 2020 · Scientific Reports
6. Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
   Boris Guennewig, Julia Lim, Lee L. Marshall, Andrew N. McCorkindale, Patrick Jarmo Paasila, Ellis Patrick, Jillian J. Kril, Glenda Margaret Halliday, Antony A. Cooper, Greg Trevor Sutherland · 2021 · Scientific Reports
7. Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer's disease models
   Daidi Li, Chang-Qing Zheng, Feng Zhang, Jing-Shan Shi · 2021 · Neural Regeneration Research
8. MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
   Nermeen Zakaria AbuelEzz, Fayza Eid Nasr, Mohammad A. Abdulkader, Ahmad Raafat Bassiouny, Amira Zaky · 2021 · Frontiers in Aging Neuroscience
9. Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties
   Olga G. Tatarnikova, М. А. Орлов, Natalia V. Bobkova · 2015 · Biochemistry (Moscow)
10. The Full Spectrum of Alzheimer’s Disease Is Rooted in Metabolic Derangements That Drive Type 3 Diabetes
    Suzanne M. de la Monte · 2019 · Advances in experimental medicine and biology
11. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
    Sebastiano Intagliata, Loredana Salerno, Valeria Ciaffaglione, Carmen Leonardi, Antonino Nicolò Fallica, Giuseppe Carota, Emanuele Amata, Agostino Marrazzo, Valeria Pittalà, Giuseppe Romeo · 2019 · European Journal of Medicinal Chemistry
12. Upregulation of AMPK Ameliorates Alzheimer’s Disease-Like Tau Pathology and Memory Impairment
    Lin Wang, Na Li, Fang-Xiao Shi, Weiqi Xu, Yun Cao, Ying Lei, Jian‐Zhi Wang, Qing Tian, Xinwen Zhou · 2020 · Molecular Neurobiology
13. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease
    Matteo Pedrazzoli, Morris Losurdo, Giovanna Paolone, Manuela Medelin, Lejdi Jaupaj, Barbara Cisterna, Anna Slanzi, Manuela Malatesta, Silvia Coco, Mario Buffelli · 2019 · Neurobiology of Disease
14. Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
    Kok Pin Ng, Hui Jin Chiew, Pedro Rosa‐Neto, Nagaendran Kandiah, Zahinoor Ismail, Serge G. Gauthier · 2021 · Translational Neurodegeneration
15. Synthesis, kinetic evaluation and molecular docking studies of donepezil-based acetylcholinesterase inhibitors
    Makar Makarian, Michael Gonzalez, Stephanie M. Salvador, Shahrokh Lorzadeh, P. K. Hudson, Stevan Pecic · 2021 · Journal of Molecular Structure
16. Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging
    Nicholas R W Cleland, Saif I. Al‐Juboori, Evgenia Dobrinskikh, Kimberley D. Bruce · 2021 · Journal of Neuroinflammation
17. Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
    Ranran Lu, Lijie Zhang, Xinling Yang · 2022 · Frontiers in Aging Neuroscience
18. Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
    Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja · 2023 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
19. Alzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics
    Aimi Syamima Abdul Manap, Reema Almadodi, Shirin Sultana, Maheishinii Grace Sebastian, Kenil Sureshbhai Kavani, Vanessa Elle Lyenouq, Aravind Shankar · 2024 · Frontiers in Aging Neuroscience
20. Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice
    Rachelle L. Crescenzi, Catherine DeBrosse, Ravi Prakash Reddy Nanga, Matthew D. Byrne, Guruprasad Krishnamoorthy, Kevin D’Aquilla, Hari Nath, Knashawn H. Morales, Michiyo Iba, Hari Hariharan et al. · 2016 · Hippocampus
21. Neuroprotective effects of Coptis chinensis Franch polysaccharide on amyloid-beta (Aβ)-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer's disease (AD)
    Yujuan Li, Shuwen Guan, Cong Liu, Xinhua Chen, Yuemei Zhu, Yutong Xie, Jianbin Wang, Xue Ji, Liqin Li, Zhuohan Li et al. · 2018 · International Journal of Biological Macromolecules
22. Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases
    Amit U. Joshi, Daria Mochly‐Rosen · 2018 · Pharmacological Research
23. Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure
    The Dominantly Inherited Alzheimer Network (DIAN), Li, Zeran, Del-Aguila, Jorge L., Dube, Umber, Budde, John, Martinez, Rita, Black, Kathleen, Xiao, Qingli, Cairns, Nigel J., Dougherty, Joseph D. et al. · 2018 · Genome Medicine
24. Repurposing ibudilast to mitigate Alzheimer’s disease by targeting inflammation
    Giovanni Oliveros, Charles H Wallace, Osama Chaudry, Qiao Liu, Yue Qiu, Lei Xie, Patricia Rockwell, Maria E. Figueiredo-Pereira, Peter A. Serrano · 2022 · Brain
25. A self-driven approach for multi-class discrimination in Alzheimer's disease based on wearable EEG
    Eduardo Perez‐Valero, M. A. López-Gordo, Christian A. Morillas, Ismael Carrera-Muñoz, Rosa M. Vílchez-Carrillo · 2022 · Computer Methods and Programs in Biomedicine
26. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer’s Disease
    Sage J. B. Dunham, Katelyn A. McNair, Eric D. Adams, Julio Avelar‐Barragan, Stefânia Forner, Mark E. Mapstone, Katrine Whiteson · 2022 · mBio
27. JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer’s disease
    Chiara Scopa, Samantha M. Barnada, M. Cicardi, Sing-Er Mo, D. Trotti, M. Trizzino · 2022 · bioRxiv
28. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
    Nicholas Lim, Christine R. Swanson, H.R.R. Cherng, Travis L. Unger, Sharon Xiangwen Xie, Daniel A. Weintraub, KENNETH L. MAREK, Matthew B. Stern, Andrew D. Siderowf, PARS Investigators et al. · 2016 · Annals of Clinical and Translational Neurology
29. Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention?
    Warnakulasuriya Mary Ann Dipika Binosha Fernando, Geeshani Somaratne, Kathryn G. Goozee, Shehan Williams, Harjinder Singh, Ralph Nigel Martins · 2017 · Journal of Alzheimer s Disease
30. A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases
    Laura Louise Scott, Tim G. Downing · 2017 · Toxins
31. Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
    Saak Victor Ovsepian, Valerie B. O’Leary, László Záborszky, Vasilis Ntziachristos, James Oliver Dolly · 2018 · Alzheimer s & Dementia
32. Chlorella sorokiniana and Chlorella minutissima exhibit antioxidant potentials, inhibit cholinesterases and modulate disaggregation of β-amyloid fibrils
    Tosin Abiola Olasehinde, Ejovwokoghene Collins. Odjadjare, Leonard V. Mabinya, Ademola Olufolahan Olaniran, Anthony Ifeanyi Okoh · 2019 · Electronic Journal of Biotechnology
33. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
    Rasool Haddadi, Zahra Shahidi, Shahla Eyvari Brooshghalan · 2020 · Phytomedicine
34. Glio-vascular changes during ageing in wild-type and Alzheimer׳s disease-like APP/PS1 mice
    Cátia S. Janota, Dora Maria Tuna Oliveira Brites, Cynthia Ann Lemere, María Alexandra Brito · 2015 · Brain Research
35. Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
    Abate, Giulia, Memo, Maurizio, Uberti, Daniela · 2020 · Healthcare
36. Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking
    André Voelzmann, Pilar Okenve-Ramos, Yue Qu, Monika Chojnowska-Monga, Manuela del Caño-Espinel, Andreas Prokop, Natalia Sánchez‐Soriano · 2016 · eLife
37. Luminescent Ru(II) Phenanthroline Complexes as a Probe for Real-Time Imaging of Aβ Self-Aggregation and Therapeutic Applications in Alzheimer’s Disease
    Débora E.S. Silva, Mariana P. Cali, Wallance Moreira Pazin, Estêvão Carlos-Lima, Maria Teresa Salles Trevisan, Tiago Venâncio, Manoel Arcísio-Miranda, Amando Siuiti Ito, Rose Maria Carlos · 2016 · Journal of Medicinal Chemistry
38. Visual Dysfunction in Posterior Cortical Atrophy
    Mari Nilva Maia da Silva, Rebecca S. Millington, Holly Bridge, Merle James-Galton, Gordon Terence Plant · 2017 · Frontiers in Neurology
39. Ammon’s Horn 2 (CA2) of the Hippocampus: A Long-Known Region with a New Potential Role in Neurodegeneration
    Cindy Chi-Ching Pang, Clemens Martin Kiecker, John Tiernan O'Brien, Wendy J. Noble, Raymond Chuen‐Chung Chang · 2018 · The Neuroscientist
40. Differential effects of putative N-glycosylation sites in human Tau on Alzheimer’s disease-related neurodegeneration
    Losev, Yelena, Frenkel-Pinter, Moran, Abu-Hussien, Malak, Viswanathan, Guru Krishnakumar, Elyashiv-Revivo, Donna, Geries, Rana, Khalaila, Isam, Gazit, Ehud, Segal, Daniel · 2021 · Cellular and Molecular Life Sciences
41. Alzheimer´s Disease associated with Psychiatric Comorbidities
    Michelle Lima Garcez, Ana Carolina Brunatto Falchetti, Francielle Mina, Josiane Budni · 2015 · Anais da Academia Brasileira de Ciências
42. Neuroprotective and Anti-Inflammatory Effects of Low–Moderate Dose Ionizing Radiation in Models of Alzheimer’s Disease
    Sujin Kim, Yunkwon Nam, Chanyang Kim, Hyewon Lee, Seo-Jin Hong, Hyeon soo Kim, Soo Jung Shin, Yong Ho Park, Han Ngoc Mai, Sang‐Muk Oh et al. · 2020 · International Journal of Molecular Sciences
43. Microglial Immunometabolism in Alzheimer’s Disease
    Daniel C. Shippy, Tyler Kent Ulland · 2020 · Frontiers in Cellular Neuroscience
44. Metabolic disorder in Alzheimer’s disease
    Mrinal Kanti Poddar, Soumyabrata Banerjee, Apala Chakraborty, Debasmita Dutta · 2021 · Metabolic Brain Disease
45. Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches
    Kiran Kumar Siddappaji, Shubha Gopal · 2021 · AIMS neuroscience
46. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development
    Medha Karnik, Narasimha Murthy Beeraka, Chinnappa A. Uthaiah, Suma Maduvanahalli Nataraj, Anjali Devi S. Bettadapura, Gjumrakch M. Aliev, SubbaRao V. Madhunapantula · 2021 · Molecular Neurobiology
47. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers
    Ladan Amin, David A. Harris · 2021 · Nature Communications
48. Object recognition test for studying cognitive impairments in animal models of Alzheimer s disease
    María Javier Ramírez · 2015 · Frontiers in Bioscience-Scholar
49. Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
    Jianping Guo, Ji Cheng, Brian J. North, Wenyi Wei · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
50. Oral treatment with royal jelly improves memory and presents neuroprotective effects on icv-STZ rat model of sporadic Alzheimer's disease
    Tiago Guardia de Souza e Silva, Maria Eliza Ferreira do Val de Paulo, Jeferson Rubens Mamona da Silva, Adilson da Silva Alves, Luiz Roberto Giorgetti de Britto, Gilberto Fernando Xavier, Maria Regina Lopes Sandoval · 2020 · Heliyon
51. Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer’s disease
    Daniel T. Ohm, Angela J. Fought, Adam Martersteck, Christina Coventry, Jaiashre Sridhar, Tamar D. Gefen, Sandra Weıntraub, Eileen H. Bigio, Marsel M. Mesulam, Emily Joy Rogalski et al. · 2020 · Brain Pathology
52. Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease
    Tropea, Maria Rosaria, Gulisano, Walter, Vacanti, Valeria, Arancio, Ottavio, Puzzo, Daniela, Palmeri, Agostino · 2022 · Free Radical Biology and Medicine
53. Long-term effects of amyloid-beta deposits in human iPSC-derived astrocytes
    Evangelos Konstantinidis, Abdulkhalek Dakhel, Chiara Beretta, Anna Erlandsson · 2023 · Molecular and Cellular Neuroscience
54. Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders
    Md Jamir Anwar, Sattam Khulaif Alenezi, Ahmad Hamad Alhowail · 2023 · Biomedicine & Pharmacotherapy
55. Prospects and challenges of tissue-derived extracellular vesicles
    Changjoon Justin Lee, Roslyn Michelle Ray, Tristan A. Scott · 2024 · Molecular Therapy
56. Spatial training preserves associative memory capacity with augmentation of dendrite ramification and spine generation in Tg2576 mice
    Xia Jiang, Gaoshang Chai, Zhi-Hao Wang, Yu Hu, Xiaoguang Li, Zhiwei Ma, Qun Wang, Jian‐Zhi Wang, Gong‐Ping Liu · 2015 · Scientific Reports
57. Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice
    Claire S. Durrant, Michael P. Coleman · 2016 · Molecular Neurodegeneration
58. Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism
    Eugenio Barone, Andrea Arena, Elizabeth Head, David Allan Butterfield, Marzia Perluigi A · 2017 · Free Radical Biology and Medicine
59. In Vitro Anti-Cholinesterase and Antioxidant Activity of Extracts of Moringa oleifera Plants from Rivers State, Niger Delta, Nigeria
    Lucky Legbosi Nwidu, Ekramy Mahmoud Elmorsy, Jonah Sydney Aprioku, IM Siminialayi, Wayne Grant Carter · 2018 · Medicines
60. Identification of Alzheimer’s Disease Autoantibodies and Their Target Biomarkers by Phage Microarrays
    Pablo San Segundo‐Acosta, Ana Montero‐Calle, Manuel Fuentes, Alberto Rábano, Mayte Villalba, Rodrigo Barderas · 2019 · Journal of Proteome Research
61. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
    Lei Li, Xiang‐Hui Wu, Xiao-Jing Zhao, Lu Xu, Cailong Pan, Zhiyuan Zhang · 2020 · Journal of Neuroinflammation
62. Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
    Daniela C. Ivan, Sabrina Walthert, Kristina Berve, Jasmin Steudler, Giuseppe Locatelli · 2021 · Frontiers in Immunology
63. A Reduced Astrocyte Response to β-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment
    Mathur, Ryan, Ince, Paul G., Minett, Thais, Garwood, Claire J., Shaw, Pamela J., Matthews, Fiona E., Brayne, Carol, Simpson, Julie E., Wharton, Stephen B., on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group · 2015 · PLOS ONE
64. An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.
    Xiaoling Zhou, Yifei Li, Xiaozhe Shi, Chun Ma · 2016 · PubMed Central
65. Aging-Dependent Mitophagy Dysfunction in Alzheimer’s Disease
    Mingxue Song, Xiulan Zhao, Fuyong Song · 2021 · Molecular Neurobiology
66. Leveraging hallmark Alzheimer’s molecular targets using phytoconstituents: Current perspective and emerging trends
    Prajakta A. Dhage, Archana Ashok Sharbidre, Sarada Prasad Dakua, Shidin Balakrishnan · 2021 · Biomedicine & Pharmacotherapy
67. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau
    Anastasie Maté de Gérando, Lindsay A. Welikovitch, Anita Khasnavis, Caitlin Commins, Calina A. Glynn, Joshua E Chun, Romain Perbet, Bradley T. Hyman · 2023 · Acta Neuropathologica
68. Amyloid Precursor Protein Translation Is Regulated by a 3’UTR Guanine Quadruplex
    Ezekiel Matthew David Crenshaw, Brian Chun Lok Leung, Chun Kit Kwok, Michal A. Sharoni, Kalee J. Olson, Neeraj P. Sebastian, Sara Ansaloni, Reinhard Schweitzer‐Stenner, Michael R. Akins, Philip C. Bevilacqua et al. · 2015 · PLoS ONE
69. Fornical Closed-Loop Stimulation for Alzheimer’s Disease
    Sühan Senova, Antoine Chaillet, Andrés M. Lozano · 2018 · Trends in Neurosciences
70. Analysis of electroencephalographic signals complexity regarding Alzheimer's Disease
    Katerina D. Tzimourta, Theodora Afrantou, Panagiotis Ioannidis, Maria Karatzikou, Alexandros T. Tzallas, Νικόλαος Γιαννακέας, Loukas G. Astrakas, Pantelis A. Angelidis, Euripidis Glavas, Nikolaos Grigoriadis et al. · 2019 · Computers & Electrical Engineering
71. Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease
    Abdullah Al Mamun, Md. Sahab Uddin, Md. Fahim Bin Bashar, Sonia Zaman, Yesmin Begum, Israt Jahan Bulbul, Md. Siddiqul Islam, Md Shahid Sarwar, Bijo Mathew, Md. Shah Amran et al. · 2020 · Oxidative Medicine and Cellular Longevity
72. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets
    Jessika Royea, Édith Hamel · 2020 · GeroScience
73. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases
    Gloria Biechele, Nicolai Franzmeier, Tanja Blume, Michael Ewers, José Medina-Luque, Florian Eckenweber, Christian Sacher, Leonie Beyer, François Ruch, Simon Lindner et al. · 2020 · Journal of Neuroinflammation
74. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice
    Marangelie Criado‐Marrero, Niat T. Gebru, Danielle M. Blazier, Lauren A. Gould, Jeremy D. Baker, David Beaulieu‐Abdelahad, Laura J. Blair · 2021 · Acta Neuropathologica Communications
75. Evidence of Neurovascular Un-Coupling in Mild Alzheimer’s Disease through Multimodal EEG-fNIRS and Multivariate Analysis of Resting-State Data
    Antonio Maria Chiarelli, David Perpetuini, Pierpaolo Croce, Chiara Filippini, Daniela Cardone, Ludovica Rotunno, Nelson Anzoletti, M. Zito, Filippo Zappasodi, Arcangelo Merla · 2021 · Biomedicines
76. Tau and β-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep
    Joseph R. Winer, Allison Brooke Morehouse, Laura E. Fenton, Theresa M. Harrison, Lylian Ayangma, Mark E. Reed, Samika Kumar, Suzanne L. Baker, William J. Jagust, Matthew P. Walker · 2021 · Journal of Neuroscience
77. PET Imaging of Translocator Protein (18 kDa) in a Mouse Model of Alzheimer's Disease UsingN-(2,5-Dimethoxybenzyl)-2-18F-Fluoro-N-(2-Phenoxyphenyl)Acetamide
    Michelle Louise James, Nadia P. Belichenko, Thuy‐Vi V. Nguyen, Lauren Andrews, Zhaoqing Ding, Hongguang Liu, Deepika Bodapati, Natasha Arksey, Bin Shen, Zhen Cheng et al. · 2015 · Journal of Nuclear Medicine
78. Entorhinal cortical defects in Tg2576 mice are present as early as 2–4 months of age
    Áine Duffy, José Morales‐Corraliza, Keria Bermudez‐Hernandez, Michael J. Schaner, Alejandra Magagna‐Poveda, Paul M. Mathews, Helen E. Scharfman · 2014 · Neurobiology of Aging
79. Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs
    Juan Manuel Zolezzi, Sussy Bastias Candia, Manuel J. Santos, Nibaldo C. Inestrosa · 2014 · Frontiers in Aging Neuroscience
80. Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice
    Carmen Infante‐Garcia, Juan José Ramos‐Rodríguez, Irene Delgado-Olmos, Carlos Gamero-Carrasco, María Teresa Fernández-Ponce, Lourdes Casas, Casimiro Mantell, Mónica Garcı́a-Alloza · 2016 · Molecular Neurobiology
81. Resistance Exercise Decreases Amyloid Load and Modulates Inflammatory Responses in the APP/PS1 Mouse Model for Alzheimer’s Disease
    Debora Hashiguchi, Henrique Correia Campos, Raphael Wuo‐Silva, Jean Faber, Sérgio Gomes da Silva, Antônio Augusto Coppi Maciel Ribeiro, Ricardo Mário Arida, Beatriz M. Longo · 2020 · Journal of Alzheimer s Disease
82. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
    Christian Sacher, Tanja Blume, Leonie Beyer, Finn Peters, Florian Eckenweber, Carmelo Sgobio, Maximilian Deußing, Nathalie L. Albert, Marcus Unterrainer, Simon Lindner et al. · 2019 · Journal of Nuclear Medicine
83. Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients
    Yulia A. Sidorova, Andrii Domanskyi · 2020 · Methods and Protocols
84. VEGF counteracts amyloid-β-induced synaptic dysfunction
    Laurent Martin, Pauline Bouvet, Naura Chounlamountri, Chantal Watrin, Roger Besançon, Delphine Pinatel, David Meyronet, Jérôme Honnorat, Alain Buisson, Paul Antoine Salin et al. · 2021 · Cell Reports
85. Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
    Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, Vo Van Giau · 2021 · Neurochemical Research
86. miRNAs as Therapeutic Tools in Alzheimer’s Disease
    Chang Youn Lee, In Soo Ryu, Jin‐Hyeob Ryu, Hyun‐Jeong Cho · 2021 · International Journal of Molecular Sciences
87. Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review
    Anette Hardy-Sosa, Karen León‐Arcia, Jorge J. Llibre‐Guerra, Jorge Berlanga‐Acosta, Saiyet de la C. Baez, Gerardo E Guillén, Pedro Antonio Valdes-Sosa · 2022 · Frontiers in Aging Neuroscience
88. Age-related metabolic and neurodegenerative changes in SAMP8 mice
    Andrea Pačesová, Martina Holubová, Lucie Hrubá, Veronika Strnadová, Barbora Neprašová, Helena Pelantová, Marek Kuzma, Blanka Železná, Jaroslav Kuneš, Lenka Maletı́nská · 2022 · Aging
89. Porphyromonas gingivalis outer membrane vesicles in cerebral ventricles activate microglia in mice
    Kayo Yoshida, Kaya Yoshida, Mariko Seyama, Yuka Hiroshima, Mana Mekata, Natsumi Fujiwara, Yasusei Kudo, Kazumi Ozaki · 2022 · Oral Diseases
90. Extra-Virgin Olive Oil in Alzheimer’s Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies
    Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Amal Kaddoumi · 2024 · International Journal of Molecular Sciences
91. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients
    Miranka Wirth, Alexa Pichet Binette, Peter Brunecker, Theresa Köbe, A. Veronica Witte, Agnes Flöel · 2016 · Journal of Cerebral Blood Flow & Metabolism
92. Neuroprotective Activity of Asparagus racemosus Linn. Against Ethanol- Induced Cognitive Impairment and Oxidative Stress in Rats Brain: Auspicious for Controlling the Risk of Alzheimer’s Disease
    Md. Sahab Uddin, Md. Asaduzzaman · 2016 · Journal of Alzheimer’s Disease & Parkinsonism
93. Brain glucose metabolism: Role of Wnt signaling in the metabolic impairment in Alzheimer’s disease
    Pedro Cisternas, Nibaldo C. Inestrosa · 2017 · Neuroscience & Biobehavioral Reviews
94. Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer’s disease
    Narendran Annadurai, Khushboo Agrawal, Petr Džubák, Marián Hajdúch, Viswanath Das · 2017 · Cellular and Molecular Life Sciences
95. Short-term exposure to dim light at night disrupts rhythmic behaviors and causes neurodegeneration in fly models of tauopathy and Alzheimer's disease
    Mari Kim, Manivannan Subramanian, Yun-Ho Cho, Gye-Hyeong Kim, Eunil Lee, Joong‐Jean Park · 2017 · Biochemical and Biophysical Research Communications
96. Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN
    Qinyuan Xu, Sijia Cao, Sanjeeva Rajapakse, Joanne Aiko Matsubara · 2018 · Lipids in Health and Disease
97. Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1–42)
    Tamás Letoha, Anett Hudák, Erzsébet Kúsz, Aladár Pettkó‐Szandtner, Ildikó Domonkos, Katalin Jósvay, Martin Hofmann‐Apitius, László Szilák · 2019 · Scientific Reports
98. Extracellular Vesicles: A Possible Link between HIV and Alzheimer’s Disease-Like Pathology in HIV Subjects?
    Sunitha Kodidela, Kelli A. Gerth, Sanjana Haque, Yuqing Gong, Saifudeen Ismael, Ajay Kumar Singh, Tauheed Ishrat, Santosh Kumar · 2019 · Cells
99. Renin-Angiotensin System and Alzheimer’s Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives
    Victor Teatini Ribeiro, Leonardo Cruz de Souza, Ana Cristina Simões e Silva · 2019 · Protein and Peptide Letters
100. Tau Propagation as a Diagnostic and Therapeutic Target for Dementia: Potentials and Unanswered Questions
     Shuko Takeda · 2019 · Frontiers in Neuroscience